Advertisement
Screener

Valion Bio, Inc. (VBIO) Net Margin

Valion Bio, Inc. (VBIO) Net Margin

  • 2025-09-30: Net Margin -1778.08%.
  • 2025-06-30: Net Margin -2245.35%.
  • 2025-03-31: Net Margin -2145.71%.
  • 2024-12-31: Net Margin -820.56%.

Complete source-backed net margin history.

Available history
2021-03-31 to 2025-09-30
Data captured

Historical Net Margin

DateNet Margin
2025-09-30-1778.08%
2025-06-30-2245.35%
2025-03-31-2145.71%
2024-12-31-820.56%
2024-09-30-1135.71%
2024-06-30-904.29%
2024-03-31-443.41%
2023-12-31-628.29%
2023-09-30-624.11%
2023-06-30-1319.88%
2023-03-31-562.77%
2022-12-31-552.45%
2022-09-30-541.72%
2022-06-30-571.59%
2022-03-31-523.36%
2021-12-31-957.33%
2021-09-30-837.55%
2021-06-30-408.21%
2021-03-31-419.81%

Annual Net Margin

DateNet Margin
2024-12-31-725.00%
2023-12-31-701.02%
2022-12-31-548.70%
2021-12-31-675.74%

Similar stocks

Stock NameCountryMarket CapPE Ratio
MAIA Biotechnology, Inc. (MAIA)United States$0.077B-2.30
iBio, Inc. (IBIO)United States$0.077B-2.94
Adicet Bio, Inc. (ACET)United States$0.078B-0.81
Lifevantage Corp (LFVN)United States$0.078B15.40
Verrica Pharmaceuticals Inc. (VRCA)United States$0.076B-3.39
OS Therapies Inc (OSTX)United States$0.076B-2.17
Gain Therapeutics, Inc. (GANX)United States$0.080B-4.40
Aldeyra Therapeutics, Inc. (ALDX)United States$0.074B-5.57
Cingulate Inc. (CING)United States$0.073B-2.64
Spero Therapeutics, Inc. (SPRO)United States$0.073B17.41